Second Avenue Capital Partners Makes Various Leadership Transitions
Second Avenue Capital Partners (SACP), the specialty finance affiliate of SB360 Holdings, made a leadership transition as Chris O’Connor, president...
Forward for Specialty Finance
Hilco Global Launches Two New Advisory Practices with Strategic Executive Appointments
Hilco Global, a diversified financial services advisory and investment company, appointed two distinguished executives — Hon. Patrick J. Murphy as...
Former JPMorgan Executive Capin Acquires CoreVision
Kennedy Capin, a respected leader and former lender in the asset-based lending (ABL) industry, is acquiring CoreVision Strategies, a provider...
TAB Bank Prescribes $2MM Asset-Based Line of Credit for Financing and Logistics Company
TAB Bank has provided a $2 million revolving asset-based line of credit for a Canadian medical supply chain financing and...
Attorneys from Saavedra Goodwin Join New York Law Firm Moritt Hock & Hamroff
Moritt Hock & Hamroff, a New York-based commercial law firm, expanded its capabilities in South Florida when the attorneys from...
Gioia Joins Asset-Based Lending Originations at Webster Bank
Webster Bank added Dan Gioia to its asset-based lending (ABL) division as senior managing director, third party and large corporate...
Voyager Closes $200MM Credit Facility Led by J.P. Morgan
Voyager Technologies, a global company in defense technology and space solutions, closed a $200 million syndicated credit facility led by...
NeuroPace Secures Up to $75MM in Debt Financing with MidCap Financial
NeuroPace, a medical device company focused on transforming the lives of people living with epilepsy, entered into a new $75...
Starwood Capital Group Closes Private-Credit Focused Vehicles at Total Valuation of $2.86B
Starwood Capital Group, a global private investment firm, closed its latest private credit-focused vehicles: Starwood Real Estate Debt Strategies U.S. (SREDS), Starwood...
Vera Therapeutics Refinances Existing Oxford Debt Facility, Providing Up to $500MM of Term Loans
Vera Therapeutics, a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases,...
